肝损伤
医学
药品
临床前试验
重症监护医学
动物模型
上市后监督
临床试验
肝功能
透视图(图形)
风险分析(工程)
功能(生物学)
药理学
生物信息学
计算机科学
不利影响
病理
生物
医学物理学
内科学
人工智能
进化生物学
作者
Yingying Pan,Mingzhu Cao,Danming You,Genggeng Qin,Zhi Liu
摘要
Drug-induced liver injury (DILI) is a major concern in clinical studies as well as in postmarketing surveillance. It is necessary to establish an animal model of DILI for thorough investigation of mechanisms of DILI and searching for protective medications. This article reviews the current status and future perspective on establishment of DILI models based on different hepatotoxic drugs, as well as the underlying mechanisms of liver function damage induced by specific medicine. Therefore, information from this article can help researchers make a suitable selection of animal models for further study.
科研通智能强力驱动
Strongly Powered by AbleSci AI